Navigation Links
Wyeth Pharmaceuticals Announces Organizational Change
Date:6/26/2008

- Andreas Krebs Named President of Europe/Middle East/Africa and Canada -

COLLEGEVILLE, Pa., June 26 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today the appointment of Andreas Krebs, 50, to President - Europe/Middle East/Africa and Canada, effective immediately. In this new role, Mr. Krebs will report to Joseph M. Mahady, President - Wyeth Pharmaceuticals, and Senior Vice President, Wyeth.

Mr. Krebs joined the Company in July 2003 as General Manager, Wyeth Germany, and since that time has worked to transform the German affiliate into one of the fastest growing companies in the market. He serves on the Board of the VFA (Germany's trade organization for research companies) and is a member of the Board of Trustees in the Max Planck Institute for Molecular Biomedicine and the Paul Ehrlich Society for Chemotherapy.

Prior to joining Wyeth, Mr. Krebs was with Bayer for approximately 20 years, where he held a variety of pharmaceutical marketing and sales leadership positions in Europe, Latin America, Asia and Canada. He holds a degree in Commercial Management and Business Administration from the In-House Academy of Woelm Pharma, Eschwege, Germany.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
2. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
3. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
4. Wyeth Chairman Robert Essner Announces June 27 Retirement
5. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
6. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
7. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
8. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
9. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
10. Wyeth Announces Executive Change in Finance Organization
11. Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
Breaking Biology News(10 mins):